CN101559144A - Oral Tonglin Hushen capsule for curing urethritis, cystitis, acute pyelonephritis and chronic pyelonephritis and preparation method thereof - Google Patents
Oral Tonglin Hushen capsule for curing urethritis, cystitis, acute pyelonephritis and chronic pyelonephritis and preparation method thereof Download PDFInfo
- Publication number
- CN101559144A CN101559144A CNA2008100506075A CN200810050607A CN101559144A CN 101559144 A CN101559144 A CN 101559144A CN A2008100506075 A CNA2008100506075 A CN A2008100506075A CN 200810050607 A CN200810050607 A CN 200810050607A CN 101559144 A CN101559144 A CN 101559144A
- Authority
- CN
- China
- Prior art keywords
- cystitis
- capsule
- acute
- herba
- urethritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to an oral Tonglin Hushen capsule prepared by taking Chinese herbal medicines as raw materials and used for curing urethritis, cystitis, acute pyelonephritis and chronic pyelonephritis. Taking eight Chinese herbal medicines such as corktree, herba violae, armstrong, dianthus superbus, pyrrosia lingua, dandelion, asiatic plantain seeds and licorice as the raw materials, the capsule is obtained by nine processing steps, such as material selecting, cleaning, drying, grinding, sieving, mixing, capsule filling, split charging and packing. According to the clinical observation, the oral Tonglin Hushen capsule has the advantages of good and fast curative effect and high curative ratio for curing the urethritis, the cystitis, the acute pyelonephritis and the chronic pyelonephritis, simple manufacture, convenient taking, low cost, and the like.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of urethritis, cystitis and acute and chronic pyelonephritis, a kind of specifically is the oral medicine nephritis capsule of treatment treatment urethritis, cystitis and the acute and chronic pyelonephritis of feedstock production with the Chinese herbal medicine, the invention still further relates to the preparation method of this medicine.
Background technology
Urinary tract infection is common diseases of urinary system, refer to pathogen in body, urinate in growth and breeding, and invade mucous membrane of urethra or tissue and the inflammation that causes.Primary disease can betide each age group, and is the most common with the women especially, the urinary tract infection of about 3% women more than once taking place once in life, and bachelorette sexually transmitted disease (STD) rate is about 2%, and married woman's sickness rate increases to 5%, and is relevant with sexual life.Anemia of pregnant woman's bacteriuria incidence rate is about 7%, elderly woman and male's urine infects can be up to 10%, it can be divided into upper urinary tract infection (acute or chronic pyelonephritis) and lower urinary tract infection (cystitis and urethritis) according to the infection site difference, but be difficult to sometimes completely distinguish.Wherein cystitis accounts for the 50%-70% of urinary tract infection.At present, the clinician mostly adopts western medicine, but more with the side effect behind the Western medicine, part patient's incompatibility western medicine.
Summary of the invention
The objective of the invention is to provide a kind of treatment urethritis, the oral Tonglin Hushen capsule of cystitis and acute and chronic pyelonephritis with eliminating damp-heat, Tonglin Hushen.
Another object of the present invention provides this treatment urethritis, the preparation method of the oral Tonglin Hushen capsule of cystitis and acute and chronic pyelonephritis.
The object of the present invention is achieved like this:
This medicine is the medicament of being made by following raw materials by weight proportions:
Cortex Phellodendri 10-25 part Herba Violae 10-25 part Herba Polygoni Avicularis 10-25 part Herba Dianthi 10-25 part
Folium Pyrrosiae 10-35 part Herba Taraxaci 10-35 part Semen Plantaginis 10-35 part Radix Glycyrrhizae 10-20 part.
The weight proportion scope of preparation medicine of the present invention is:
Cortex Phellodendri 10-20 part Herba Violae 10-20 part Herba Polygoni Avicularis 10-20 part Herba Dianthi 10-20 part
Folium Pyrrosiae 10-30 part Herba Taraxaci 10-30 part Semen Plantaginis 10-30 part Radix Glycyrrhizae 10-15 part.
The weight proportion of medicine of the present invention is:
15 parts of 15 portions of Herba Dianthis of 15 parts of Herba Polygoni Avicularis of 15 portions of Herba Violaes of Cortex Phellodendri
10 parts in 20 portions of Radix Glycyrrhizaes of 20 portions of Semen Plantaginiss of 20 parts of Herba Taraxacis of Folium Pyrrosiae.
Above-mentioned each component is made medicine production method of the present invention is:
This preparation method by select materials, clean, dry, grind, sieve, mixing, encapsulated, packing, nine steps of packing finish.
With above-mentioned Chinese medicine at first will through selecting materials, clean, process such as drying, when drying, to dry below 60 ℃, grind then, after sieve in dry in the sun under the sun or at low temperature, reach 100 orders, mix then, encapsulated, packing, pack and promptly finished whole process of preparation at last.
When making this medicine, require to accomplish aseptic, free from dampness in packer's bay and the storeroom.
The present invention has the curative effect height through clinical observation, instant effect, cure rate height, taking convenience, advantage such as expense is low.
Function: eliminating damp-heat, Tonglin Hushen.
Cure mainly: urethritis, cystitis and acute and chronic pyelonephritis.
Usage and consumption: oral.A 8-10 grain, 3 times on the one.
The clinical case visual report of medicine of the present invention
This treats urethritis, cystitis, and the medicine Tonglin Hushen capsule of acute and chronic pyelonephritis is a Chinese medicine preparation, this medical instrument has eliminating damp-heat, the effect of Tonglin Hushen.Observe this invention medicine by 290 routine clinical cases and have the curative effect height in treatment aspect the urinary tract infection the court, and advantage such as have no side effect.
One, case is selected
15-30 year 29 examples among the 125 routine urethritis patients; 31-45 year 33 examples; 46-60 year 36 examples; 61-74 year 27 examples.15-30 year 47 examples among the 165 routine cystitis patients; 31-45 year 39 examples; 46-60 year 41 examples; 61-70 year 38 examples.
Two, diagnosis basis
According to " clinical disease diagnosis is according to curing the improvement standard " diagnosis basis
The urethritis diagnosis basis:
1, acute stage,, urethra had burn feeling, increase the weight of when urinating, so that dysuria.The sense of pruritus or ant row is only arranged when transferring chronic phase to.
2, the external orifice of urethra redness has purulent secretion.Along urethra tenderness can be arranged.
3, in the urine red, the leukocyte of volume is arranged.First glass of urine of three-glass test is obviously undesired.
4, urethral secretions smear for microscopic examination can be differentiated mutually with gonococcal urethritis.
5, urethral secretions or prostatic fluid are made PCR and are checked that pathogen such as gonococcus, mycoplasma, chlamydia etc. are to get rid of sexually transmitted disease (STD).
The cystitis diagnosis basis:
(1) acute cystitis
1, burst frequent micturition, urgent micturition and dysurea.Suprapubic region discomfort or pain.Many no General Symptomies.
2, naked eyes terminal hematuria, total hematuria or pyuria.
3, suprapubic region can have tenderness.
4, the urine mirror is checked down red, leukocyte or pus cell.The urine positive bacterial culture.
(2) chronic cystitis
1, the acute cystitis history of attack is arranged.Slight frequent micturition, urgent micturition and dysurea.
2, routine urianlysis continues to have red, leukocyte.The urine positive bacterial culture.
3, cystoscopy: mucous membrane of urinary bladder is pale, and blood vessel reduces, or has folliculus shape, water pocket shape, granulation shape to change.
4, get biopsy in case of necessity to clarify a diagnosis.
5, the visible bladder of cystography edge is rough, indentation.
Three, cure the improvement standard
Cure the improvement standard according to " clinical disease diagnosis is according to curing the improvement standard "
The urethritis criterion of cure: transference cure, unobstructed micturition, routine urianlysis is normal.The improvement standard: doing well,improving, external orifice of urethra have a small amount of secretions.Routine urianlysis is undesired.
The cystitis criterion of cure:
1, symptom complete obiteration, and do not have outbreak repeatedly.
2, repeatedly routine urianlysis is normal.Continuous 3 urine thin bacterium are cultivated negative.
The improvement standard:
1, irritation sign of bladder obviously alleviates, but recurrence is arranged.
2, red, the leukopenia of urine.The urine thin born of the same parents cultivate still positive sometimes.
3, cystoscopy: inflammation changes not complete obiteration.
Four, usage and dosage
Oral Tonglin Hushen capsule.A 8-10 grain, 3 times on the one, one month is a course of treatment.
Five, conclusion analysis
Table 1, oral Tonglin Hushen capsule treatment urethritis 125 examples are observed, and see the following form:
| Age | Case load | Cure | Take a turn for the better |
| 15-30 | 29 | 22(75.86％) | 7(24.14％) |
| 31-45 | 33 | 24(72.73％) | 9(27.27％) |
| 46-60 | 36 | 27(75％) | 9(25％) |
| 61-74 | 27 | 20(74.07％) | 7(25.93％) |
| Amount to | 125 | 93(74.4％) | 32(25.6％) |
As can be seen from Table 1, this medicine is cured 93 examples, cure rate 74.4% to the treatment urethritis; 32 examples that take a turn for the better, improvement rate 25.6%.
Table 2, oral Tonglin Hushen capsule treatment cystitis 165 examples are observed, and see the following form:
| Age | Case load | Cure | Take a turn for the better |
| 15-30 | 47 | 37(78.72％) | 10(21.28％) |
| 31-45 | 39 | 30(76.92％) | 9(23.08％) |
| 46-60 | 41 | 32(78.05％) | 9(21.95％) |
| 61-70 | 38 | 28(73.68％) | 10(26.32％) |
| Amount to | 165 | 127(76.97％) | 38(23.03％) |
This medicine is cured 127 examples, cure rate 76.97% to the treatment cystitis as can be seen from Table 2; 38 examples that take a turn for the better, improvement rate 23.03%.
Description of drawings
Fig. 1 is preparation technology's flow chart of medicine of the present invention.
The specific embodiment
The preparation method of from Fig. 1, learning this medicine by select materials, clean, dry, grind, sieve, mixing, encapsulated, packing, nine steps of packing finish.At first choose raw material 1: 15 kilograms of Cortex Phellodendris, 15 kilograms of Herba Violaes, 15 kilograms of Herba Polygoni Avicularis, 15 kilograms of Herba Dianthis, 20 kilograms of Folium Pyrrosiaes, 20 kilograms of Herba Taraxacis, 20 kilograms of Semen Plantaginiss, 10 kilograms in Radix Glycyrrhizae according to proportioning dosage, clean set by step, dry, when drying, to dry below 60 ℃ in dry in the sun under the sun or low temperature, and then grind, after sieve, to reach 100 orders, mix, encapsulated, packing, pack, finish whole processing step at last, this medicine is with every dress 0.25g preparation, 100 every bottle.
Claims (6)
1, a kind of oral medicine nephritis capsule of treatment urethritis, cystitis and acute and chronic pyelonephritis, it is characterized in that: this medicine is the medicament of being made by following raw materials by weight proportions:
Cortex Phellodendri 10-25 part Herba Violae 10-25 part Herba Polygoni Avicularis 10-25 part Herba Dianthi 10-25 part
Folium Pyrrosiae 10-35 part Herba Taraxaci 10-35 part Semen Plantaginis 10-35 part Radix Glycyrrhizae 10-20 part.
2, the oral medicine nephritis capsule of a kind of treatment urethritis, cystitis and acute and chronic pyelonephritis according to claim 1 is characterized in that: the weight proportion scope of preparation medicine of the present invention is:
Cortex Phellodendri 10-20 part Herba Violae 10-20 part Herba Polygoni Avicularis 10-20 part Herba Dianthi 10-20 part
Folium Pyrrosiae 10-30 part Herba Taraxaci 10-30 part Semen Plantaginis 10-30 part Radix Glycyrrhizae 10-15 part.
3, the oral medicine nephritis capsule of a kind of treatment urethritis, cystitis and acute and chronic pyelonephritis according to claim 1, it is characterized in that: the weight proportion of medicine of the present invention is:
15 parts of 15 portions of Herba Dianthis of 15 parts of Herba Polygoni Avicularis of 15 portions of Herba Violaes of Cortex Phellodendri
10 parts in 20 portions of Radix Glycyrrhizaes of 20 portions of Semen Plantaginiss of 20 parts of Herba Taraxacis of Folium Pyrrosiae.
4, the oral medicine nephritis capsule of a kind of treatment urethritis, cystitis and acute and chronic pyelonephritis according to claim 1, it is characterized in that: described medicament is capsule or powder.
5, according to the capsular preparation methoies of oral medicine nephritis of claim 1,2 or 3 described a kind of treatment urethritis, cystitis and acute and chronic pyelonephritis, it is characterized in that: this preparation method by select materials, clean, dry, grind, sieve, mixing, encapsulated, packing, nine steps of packing finish.
6, the capsular preparation method of oral medicine nephritis of a kind of treatment urethritis, cystitis and acute and chronic pyelonephritis according to claim 5, it is characterized in that: choose raw material, cleaning, drying in proportion, when drying, to dry below 60 ℃ in dry in the sun under the sun or at low temperature, grind then, after sieve, reach 100 orders, mix then, encapsulated, packing, pack at last and promptly finished whole preparation process, when making this medicine, require to accomplish aseptic, free from dampness in packer's bay and the storeroom.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100506075A CN101559144B (en) | 2008-04-17 | 2008-04-17 | Oral Tonglin Hushen capsule for curing urethritis, cystitis, acute pyelonephritis and chronic pyelonephritis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100506075A CN101559144B (en) | 2008-04-17 | 2008-04-17 | Oral Tonglin Hushen capsule for curing urethritis, cystitis, acute pyelonephritis and chronic pyelonephritis and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101559144A true CN101559144A (en) | 2009-10-21 |
| CN101559144B CN101559144B (en) | 2012-11-28 |
Family
ID=41218235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100506075A Expired - Fee Related CN101559144B (en) | 2008-04-17 | 2008-04-17 | Oral Tonglin Hushen capsule for curing urethritis, cystitis, acute pyelonephritis and chronic pyelonephritis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101559144B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102253009A (en) * | 2011-03-17 | 2011-11-23 | 河南科技大学 | Detection method of edible fungus specimen preserving liquid |
| CN103735695A (en) * | 2013-12-27 | 2014-04-23 | 奉娟 | Chinese medicine composition for treating urinary tract infection and preparation method thereof |
| CN105343615A (en) * | 2015-11-29 | 2016-02-24 | 刘巍 | Medicine for treating chronic pyelonephritis and preparation method |
| CN108186743A (en) * | 2013-09-12 | 2018-06-22 | 株洲千金药业股份有限公司 | A kind of preparation method of Chinese medicinal composition capsules agent for treating lower urinary tract infection |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1404868A (en) * | 2002-11-12 | 2003-03-26 | 吉林华康药业股份有限公司 | Chinese medicinal preparation for treating pyretic stranguria |
| CN1593477A (en) * | 2003-09-11 | 2005-03-16 | 谢昌贞 | Chinese herbal medicine for treating chronic prostatitis and its preparation |
-
2008
- 2008-04-17 CN CN2008100506075A patent/CN101559144B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1404868A (en) * | 2002-11-12 | 2003-03-26 | 吉林华康药业股份有限公司 | Chinese medicinal preparation for treating pyretic stranguria |
| CN1593477A (en) * | 2003-09-11 | 2005-03-16 | 谢昌贞 | Chinese herbal medicine for treating chronic prostatitis and its preparation |
Non-Patent Citations (2)
| Title |
|---|
| 冉军: "三金排石汤配合体外震波碎石治疗泌尿系结石78例", 《实用中医药杂志》 * |
| 王爱坚: "五味消毒饮临床应用新进展", 《甘肃中医》 * |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102253009A (en) * | 2011-03-17 | 2011-11-23 | 河南科技大学 | Detection method of edible fungus specimen preserving liquid |
| CN108186743A (en) * | 2013-09-12 | 2018-06-22 | 株洲千金药业股份有限公司 | A kind of preparation method of Chinese medicinal composition capsules agent for treating lower urinary tract infection |
| CN108210575A (en) * | 2013-09-12 | 2018-06-29 | 株洲千金药业股份有限公司 | A kind of preparation method for the Chinese medicine composition gelata for treating lower urinary tract infection |
| CN108272869A (en) * | 2013-09-12 | 2018-07-13 | 株洲千金药业股份有限公司 | A kind of preparation method of Chinese medicine composition oral liquid that treating lower urinary tract infection |
| CN108272868A (en) * | 2013-09-12 | 2018-07-13 | 株洲千金药业股份有限公司 | A kind of preparation method of Chinese medicine composition ointment that treating lower urinary tract infection |
| CN108272869B (en) * | 2013-09-12 | 2021-04-06 | 株洲千金药业股份有限公司 | Preparation method of traditional Chinese medicine composition oral liquid preparation for treating lower urinary tract infection |
| CN108210575B (en) * | 2013-09-12 | 2021-05-07 | 株洲千金药业股份有限公司 | Preparation method of traditional Chinese medicine composition gel for treating lower urinary tract infection |
| CN108186743B (en) * | 2013-09-12 | 2021-05-11 | 株洲千金药业股份有限公司 | Preparation method of traditional Chinese medicine composition capsule for treating lower urinary tract infection |
| CN103735695A (en) * | 2013-12-27 | 2014-04-23 | 奉娟 | Chinese medicine composition for treating urinary tract infection and preparation method thereof |
| CN105343615A (en) * | 2015-11-29 | 2016-02-24 | 刘巍 | Medicine for treating chronic pyelonephritis and preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101559144B (en) | 2012-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1078079C (en) | Process for preparing Chinese medicine 'Qianjin tablets' for treating gynopathy | |
| CN102068640B (en) | Externally-applied traditional Chinese medicine and preparation method thereof | |
| CN111544577B (en) | Female reproduction nursing preparation and preparation method thereof | |
| CN101073643B (en) | Chinese-medicinal preparation for preventing and treating hypogalactias and and gynecopathy, its production and use | |
| CN101559144B (en) | Oral Tonglin Hushen capsule for curing urethritis, cystitis, acute pyelonephritis and chronic pyelonephritis and preparation method thereof | |
| CN101869656B (en) | Chinese medicinal preparation for treating cough with asthma and preparation method thereof | |
| CN101129773A (en) | Granular formulation, tablet or capsule of black-bone chicken and white phoenix and method of preparing the same | |
| CN102240318A (en) | Traditional Chinese medicine for tonifying qi and increasing breast milk | |
| CN1724022A (en) | Compound traditional Chinese medicinal prepn. for preventing and treating uterus abnormal bleeding disease, and its prepn. method | |
| CN106075537B (en) | A kind of creeping chill gel rubber material and the preparation method and application thereof | |
| CN105797123A (en) | Traditional Chinese medicinal composition for treating infertility | |
| CN104587165A (en) | Preparation process of compound fenticonazole nitrate preparation | |
| CN109045162A (en) | Chinese medicine composition and its application for treating endometriosis | |
| CN101862393B (en) | Chinese medicinal composition for treating ureaplasma urealyticum infection and preparation method thereof | |
| CN101618051B (en) | Novel medicinal use of active parts of abelmoschus manihot general flavones | |
| CN100369624C (en) | Chinese medicinal composition for treating chronic pelvic inflammation and its preparation method | |
| CN102755563A (en) | Chinese medicinal composition for treating chronic prostatitis and preparation method thereof | |
| CN103705664B (en) | One treats psoriatic pharmaceutical composition and preparation method thereof | |
| CN1679692A (en) | Medicine for gonorrhea and its preparation | |
| CN101322771A (en) | Capsules for treating gynecology inflammation | |
| CN103536706B (en) | A kind of Chinese medicine for the treatment of trimester of pregnancy monilial vaginitis smokes lotion | |
| CN101559190A (en) | Oral Yiniao Kangfu capsule for curing nocturia and preparation method thereof | |
| CN103110722B (en) | Traditional Chinese medicine for treating chronic pelvic inflammatory disease and preparation method thereof | |
| CN102670811B (en) | External medicament for treating bacterial vaginosis and colpitis mycotica | |
| CN1318061C (en) | Method for preparing medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121128 |